Home » Abbott Stent Outperforms Boston Scientific’s in Two-Year Study
Abbott Stent Outperforms Boston Scientific’s in Two-Year Study
Abbott Laboratories’ device for propping open clogged arteries prevented more heart attacks with fewer complications after two years than Boston Scientific’s rival product, a study found.
Bloomberg
Bloomberg
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May